Does EDOXABAN Cause International normalised ratio increased? 71 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 71 reports of International normalised ratio increased have been filed in association with EDOXABAN (SAVAYSA). This represents 0.9% of all adverse event reports for EDOXABAN.
71
Reports of International normalised ratio increased with EDOXABAN
0.9%
of all EDOXABAN reports
13
Deaths
43
Hospitalizations
How Dangerous Is International normalised ratio increased From EDOXABAN?
Of the 71 reports, 13 (18.3%) resulted in death, 43 (60.6%) required hospitalization, and 2 (2.8%) were considered life-threatening.
Is International normalised ratio increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EDOXABAN. However, 71 reports have been filed with the FAERS database.
What Other Side Effects Does EDOXABAN Cause?
Anaemia (663)
Cerebral infarction (419)
Gastrointestinal haemorrhage (378)
Renal impairment (359)
Cerebrovascular accident (337)
Dyspnoea (331)
General physical health deterioration (315)
Haematuria (312)
Fall (298)
Cardiac failure (272)
What Other Drugs Cause International normalised ratio increased?
WARFARIN (5,622)
RIVAROXABAN (863)
ACETAMINOPHEN (533)
ASPIRIN (448)
APIXABAN (317)
CLOPIDOGREL BISULFATE (314)
FLUINDIONE (286)
AMIODARONE (277)
FUROSEMIDE (277)
DABIGATRAN ETEXILATE (223)
Which EDOXABAN Alternatives Have Lower International normalised ratio increased Risk?
EDOXABAN vs EDOXABAN TOSILATE
EDOXABAN vs EFALIZUMAB
EDOXABAN vs EFANESOCTOCOG ALFA
EDOXABAN vs EFAVIRENZ
EDOXABAN vs EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL